Cyber Monday saleUp to 70% OFF

Investing

Thangamayil shining: The strong financials caused a price surge!Company Overview Thangamayil Jewellery Limited (TMJL) is a rapidly growing company in India with a chain of retail jewellery stores in Tamil Nadu. They specialize in selling Gold, Silver, Diamonds, and Platinum, with gold being the main source of income. The majority of their ornaments are purchased from dealers in states like Andhra Pradesh, Gujarat, Kerala, and West Bengal for sale in their stores. Established in 1947, Thangamayil is headquartered in Madurai, India. Market Capitalization ● Current Market Cap - ₹ 5,128 Cr. ● Market Cap 3-years back - ₹ 802 Cr. ● The figures indicate that the company has increased over six times in the past three years, which is truly remarkable. Revenue & Profit Growth ● In the last three years, this stock has demonstrated an impressive compounded annual growth rate of 28% in its sales figures. ● Meanwhile, the total profit growth during this period has been a modest 12%. ● The company has successfully maintained a operating profit margin of 6%, which has risen from 4% in FY24. ● For the fiscal year 2024, the earnings per share have seen a remarkable increase, soaring from 29.10 in fiscal year 2023 to 44.91. Increasing Product Demand ● Inventory Turnover Ratio ➖ This ratio typically assists in determining whether the growth in sales is primarily due to rising product prices or if it is also influenced by increased demand for the product. ➖ Current Inventory Turnover - 3.14 ➖ Inventory Turnover 3 years ago - 2.63 ➖ These figures indicate that product demand has risen over the past three years. Valuation ● P/E Ratio The company's present price-to-earnings (PE) ratio stands at 42.3, significantly higher than its 1-year median PE of 31. When we look at the industry average PE of 31.6, it indicates that the stock might be considered somewhat overvalued at this time. ● PEG Ratio The company has a PEG ratio of 1.3, indicating that its current P/E ratio is valid. ● Intrinsic Value ➖ Thangamayil Jewellery is currently trading at ₹1870, which is nearly 2.5 times its intrinsic value of ₹764, indicating that the stock is overvalued at this moment. ➖ When we compare Thangamayil to its competitors, such as Titan and Kalyan Jewellers, some interesting insights emerge. Titan's current market price (CMP) stands at ₹3560, which is nearly 5.5 times its intrinsic value of ₹652. Meanwhile, Kalyan Jewellers has a CMP of ₹545, approximately 4.7 times its intrinsic value of ₹115. ➖ These numbers don't necessarily indicate that Titan and Kalyan Jewellers are overvalued; rather, they suggest that Thangamayil could be an attractive investment choice. Debt Analysis ● Debt to Equity Ratio ➖ The company carries a debt of approximately ₹532 Cr., resulting in a debt-to-equity ratio of 1.08. ➖ When discussing debt, it's important to note that for a small-cap company, this isn't necessarily a major concern. The key factor to consider is whether the company can consistently meet its loan interest payments. ➖ To assess this, we should examine the interest coverage ratio. ● Interest Coverage Ratio With an interest coverage ratio of 5.62, it’s evident that the company is well-equipped to manage its loan interest payments regularly. Cash Flow Analysis ● Operating cash flow has seen a remarkable surge, soaring to 330 crore from just 10 crore in FY23. ● The CFO/PAT ratio is currently at 0.74 of the five-year average, indicating that the company is quite proficient at converting its profits into cash. Shareholding Pattern ● The promoters have maintained their 67.33% stake for the last three quarters. ● Foreign Institutional Investors (FIIs) have been steadily raising their stakes since June 2023, now holding 1.08%. ● Domestic Institutional Investors (DIIs) have also grown their stakes to 12.08% in June 2024, up from 11.46% in June 2023. ● At the same time, retail investors have been consistently selling their shares over the past few quarters. Mutual Fund Holding ● Notable small-cap funds such as SBI Small Cap Fund and DSP Small Cap Fund have made substantial investments in this stock, representing 0.63% and 1.55% of their total assets under management, respectively. ● Additionally, ICICI Prudential Exports and Services Fund has recently added (in July 2024) its position in this stock, accounting for approximately 1.11% of its overall portfolio value. Technical Aspects ● From a technical standpoint, this stock appear to be currently overextended. Any pullbacks could provide a valuable opportunity to take positions. ● Stock Volume & Delivery surged by 3.4 times & 3.2 times respectively vis-a-vis their 5 day average with a 5.48% move in price. Conclusion While the company primarily functions in Tamil Nadu, it's fascinating to note that this state accounts for the largest portion (40%) of India's overall gold consumption. Furthermore, the company is gearing up to make its mark in the Chennai market by launching a flagship store along with 3-4 satellite locations. Given the increasing demand for gold jewelry, we anticipate that Thangamayil Jewellery will thrive in the industry in the years ahead.
Editors' picks
NSE:THANGAMAYLLong
by GoodluckCapital
1
A Healthcare Face-Off: Apollo vs. Narayana◉ Abstract India's hospital industry is growing rapidly, valued at ₹8.35 lakh cr. ($98.98 B) in 2023, with a projected CAGR of 5.8-8.0% from 2024 to 2032. Apollo Hospitals and Narayana Hrudayalaya are two leading players, with Apollo being the largest private hospital network and Narayana Hrudayalaya known for cost-effective cardiac care. Narayana Hrudayalaya appears undervalued with a P/E ratio of 33.5 and more profitable (ROCE: 27%), making it an attractive investment option. Apollo Hospitals seems overvalued with a P/E ratio of 83.4 but remains viable for strategic entry points. Both companies are poised for growth driven by increasing healthcare demands and infrastructure expansion. Read full analysis here........ ◉ Introduction The hospital industry in India is experiencing significant growth, with the market valued at approximately ₹8.35 lakh cr. ($98.98 B) in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 5.8% to 8.0% from 2024 to 2032, potentially reaching between 13.87 lakh cr. and 16.33 lakh cr. ($164.4 B - $193.6 B) by 2032, depending on various market analyses. ◉ Growth Drivers of the Indian Hospital Industry ● Increased Healthcare Expenditure: ➖ Rising public and private spending on healthcare, with government health expenditure aiming for 2.5% of GDP by 2025. ➖ Expanding middle class with higher disposable incomes and greater access to health insurance. ● Technological Advancements: ➖ Adoption of healthcare technologies such as telemedicine and robotic automation, improving service delivery. ➖ National Digital Health Blueprint promoting innovations in e-health. ● Policy Support and Foreign Investment: ➖ Favourable government policies allowing 100% FDI in healthcare, attracting significant investments. ➖ Public-private partnerships enhancing healthcare access, especially in underserved areas. ● Demand for Specialized Services: ➖ Increasing incidence of lifestyle diseases driving demand for specialized healthcare. ➖ Growth in medical tourism as India becomes a preferred destination for cost-effective treatments. These factors are collectively propelling the growth of the hospital industry in India, positioning it for a promising future. ◉ Key players in the Indian hospital sector 1. Apollo Hospitals leads the sector with a market capitalization of approximately ₹98,646 Cr, establishing itself as the largest private hospital network in India. 2. Max Healthcare closely follows, boasting a market capitalization of around ₹97,820 Cr. 3. Fortis Healthcare is another key participant in the market, with a market capitalization of ₹48,249 Cr. 4. Global Health also ranks among the premier healthcare institutions, holding a market capitalization of ₹28,786 Cr. 5. Narayana Hrudayalaya is recognized for its cost-effective cardiac care services and maintains a notable market share with a market capitalization of ₹26,086 Cr. In this report, we will conduct an in-depth analysis and comparison between two of India's leading healthcare providers, Apollo Hospitals and Narayana Hrudayalaya. This comprehensive evaluation will assess their technical and fundamental aspects, ◉ Company Overviews ● Apollo Hospital NSE:APOLLOHOSP Apollo Hospitals was founded in 1983 by Dr. Prathap C Reddy, a visionary in the evolution of modern healthcare in India. As the first corporate hospital in the country, Apollo Hospitals is celebrated for leading the charge in the private healthcare transformation. Today, Apollo Hospitals stands as Asia's leading integrated healthcare services provider, boasting a strong footprint throughout the healthcare landscape. This includes a diverse range of services such as hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. ● Narayana Hrudalaya NSE:NH Narayana Hrudayalaya Limited is involved in providing medical and healthcare services both in India and abroad. It functions through two main divisions: Medical and Healthcare Related Services, and Others. The organization is responsible for acquiring, owning, and managing a variety of healthcare facilities, including hospitals, clinics, health centres, diagnostic centres, and nursing homes, among other related operations. Its range of services encompasses cardiology, cardiac surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, pediatrics, neonatology, gastroenterology, and oncology. Additionally, the company is active in the health insurance sector. Established in 2000, its headquarters is located in Bengaluru, India. ◉ Technical Analysis ● Apollo Hospitals ➖ The stock faced a significant obstacle near the 5,800 level, resulted in a steep drop. ➖ It later found support around 3,500 and rebounded. ➖ Following an extended period of consolidation, the price developed a Rounding Bottom pattern. ➖ A breakout ensued, leading to a price increase, but it encountered resistance close to 6,800, which triggered a pullback to the breakout point. ➖ Following a successful retest, the price surged past the previous high, reaching a new peak at 7,545. ➖ However, due to prevailing negative market sentiments, the price has since retraced and is currently trading just above its immediate support zone. ● Narayana Hrudalaya ➖ The stock price is overall in an uptrend. ➖ After reaching an all-time high close to the 1,445 level, the price experienced a decline and has since entered a consolidation phase. ➖ A Symmetrical Triangle pattern has formed on the chart. ➖ We expect an upward breakout from this pattern, which could lead to a significant price rally. ◉ Relative Strength ➖ The chart reveals that both Apollo and Narayana Hrudayalaya have underperformed the Nifty Healthcare index. Although Apollo has given a descent 31% return, Narayana lagged significantly, yielding a modest 17% return. In contrast, the Nifty Healthcare index delivered an impressive 41% return. ◉ Service Wise Revenue Breakdown ● Apollo Hospitals The company operates through three primary segments, each contributing significantly to its revenue. ➖ Healthcare services account for approximately 52% of total revenue, forming the largest share. ➖ The retail pharmacy business generates nearly 41% of total sales, while the retail health and diagnostics segment contributes the remaining 7%. ● Narayana Hrudalaya ➖ The company operates exclusively in the healthcare services sector, deriving all its revenue from this single segment. ◉ Revenue & Profit Analysis ● Apollo Hospitals Year-over-Year ➖ The company's fiscal year 2024 performance was marked by strong growth, with revenue reaching ₹19,059 crore, a 15% increase from ₹16,612 crore in FY23. ➖ EBITDA surged to ₹2,394 crore, up from ₹2,065 crore in FY23, while the EBITDA margin improved to 13% from 12%. Quarter-over-Quarter ➖ In the latest quarter ending September 2024, the company achieved its highest-ever sales of ₹5,589 crore, significantly up from ₹5,086 crore in June 2024. This quarter-on-quarter growth has been consistent since March 2022. ➖ EBITDA for the quarter was an impressive ₹816 crore, a 21% increase from ₹675 crore in June 2024. ➖ Diluted EPS (LTM) rose substantially to ₹83.31 from ₹72.13 in June 2024. ● Narayana Hrudalaya Year-over-Year ➖ In FY24, our company achieved remarkable sales growth, surging 11% to ₹5,018 crore from ₹4,525 crore in FY23. ➖ EBITDA soared to ₹1,173 crore, up from ₹987 crore in the same period, with an impressive EBITDA margin of 23%. Quarter-over-Quarter ➖ Our quarterly sales reached an all-time high of ₹1,400 crore in September, representing a 4% increase from ₹1,341 crore in June. ➖ Although EBITDA growth was modest, it still improved to ₹308 crore in September from ₹304 crore in June 2024. ➖ However, Diluted EPS experienced a decline, dropping to ₹38.85 from ₹39.72. ◉ Valuation ● P/E Ratio ➖ Apollo Hospitals' current P/E ratio stands at 83.4, down from its 1-year median of 107.7. However, this remains significantly above the industry average of 56.9, indicating overvaluation. ➖ In contrast, Narayana Hrudalaya's P/E ratio of 33.5 is slightly above its 1-year median of 32.8 and substantially below the industry average, suggesting undervaluation. ● P/B Ratio ➖ Apollo's P/B ratio of 13.15 indicates considerable overvaluation compared to the industry average of 7.18. ➖ Narayana Hrudalaya's P/B ratio of 8.14 also suggests overvaluation, albeit to a lesser extent. ● PEG Ratio ➖ Narayana's PEG ratio of 0.49 positions it as an attractive investment opportunity, especially when compared to Apollo's considerably higher PEG of 2.43. ◉ Profitability Analysis ➖ Apollo Hospitals ROCE - 15% in FY24 ➖ Narayana Hrudalaya ROCE - 27% in FY24 The significant difference in ROCE between the two healthcare giants underscores Narayana Hrudalaya's superior profitability. Narayana's impressive ROCE of 27% demonstrates its ability to efficiently utilize its total capital, comprising both equity and debt, to generate substantially higher returns. ◉ Cash Flow Analysis ➖ Apollo Hospitals has demonstrated impressive growth in its operating cash flow, surging 39% to ₹1,920 crore in FY24 from ₹1,377 crore in FY23. This robust growth underscores the company's efficiency in converting profits into cash, highlighting its strong financial health and liquidity position. ➖ In contrast, Narayana Hrudalaya has shown sluggishness in turning profits into cash, with its operating cash flow declining 2% to ₹1,067 crore in FY24 from ₹1,085 crore in FY23. ◉ Debt Analysis ➖ Apollo Hospitals' debt stands at ₹7,371 crore, resulting in a debt-to-equity ratio of 0.98, which, although relatively high, is not alarming. However, the company's low interest coverage ratio of 4.69 raises concerns about its ability to service its debt. This vulnerability may complicate repayment of borrowed loans, potentially straining Apollo's financial stability. ➖ In contrast, Narayana Hrudalaya's debt of ₹1,703 crore and debt-to-equity ratio of 0.53 indicate robust financial health. Furthermore, its impressive interest coverage ratio of 8.34 suggests the company is well-positioned to manage its debt obligations, ensuring greater financial flexibility and stability. ◉ Shareholding Pattern ● Apollo Hospitals ➖ In the September quarter, Foreign Institutional Investors (FIIs) increased their stake in Apollo Hospitals to 45.37%, up from the previous quarter. ➖ Conversely, Domestic Institutional Investors (DIIs) reduced their holdings to 19.94%, a significant decrease from 24.77% in the last quarter. ● Narayana Hrudalaya ➖ In contrast, Narayana Hrudalaya witnessed a decline in institutional investor holdings. FIIs reduced their stake to 9.69%, down from 10% in the previous quarter. ➖ Domestic Institutional Investors (DIIs) also decreased their holdings to 7.9%, down from 8.22% in the June quarter. ◉ Conclusion Following a comprehensive analysis of both technical and fundamental aspects, we conclude that Narayana Hrudalaya appears to be favorably positioned from a valuation perspective, presenting an attractive investment opportunity. However, this does not diminish Apollo Hospitals' potential. Although the stock currently appears overvalued, investors can consider accumulating shares during dips, making it a viable option for those seeking strategic entry points. The healthcare sector's promising growth trajectory, fueled by rising healthcare demands and infrastructure expansion, positions both companies for potentially excellent returns in the near future.
NSE:APOLLOHOSPLong
by GoodluckCapital
2
KPITTECH at make or break level.#kpittech - At a crucial Support region. - Fell out of the rising wedge with huge volume. -Fell out of a base with huge volume. Implying a potential stage 4 - Support zone tested several times. - Stock used to trend smoothly taking support at 200 DMA. Which is broken now. - 1300 levels are not held then the possibility of testing 1K region. Looking for reversal is now not wise. The market is sell on the rise. Any long-term investors itching to buy the dip can consider adding a very limited quantity at 1300 region. As of now looks very weak. It would be great if we get it at 1K level. I am not a fan of short selling but if anyone is good at that then keep this on radar. This is just a view please do not take a decision without consulting your financial advisors. Chart shared is just for educational purposes.
NSE:KPITTECH
by sagartharayil
Tatamotors. Go long to appease the bottom fisher in you.#Tradeideas #tatamotors : Just to appease the bottom fisher inside you one can try going long at this juncture. Tata Motors at crucial support. Forming a green candle at that region, could be a potential reversal. Entry is possible at this stage with a small quantity. More like a probe quantity. Do not risk more than 5% in this trade in my opinion. If we are catching the reversal then the reward is high. That is the sole reason for sharing this idea. Remember, these could go against the trade: 🔴Bad Q2 results. 🔴Weak Market sentiments. 🔴Need more confirmation of a reversal. 🔴Way below all Key DMAs. 🔴Bearish Structure. If you weigh in everything this is a low-probability trade. So risk less. This is just a view and not a recommendation.
NSE:TATAMOTORSLong
by sagartharayil
Kalyan Jewellers. Aiming for another up move?#Tradeideas. #klayanjewellers. After a strong stage 2 uptrend, the stock is pulling back forming a Flag and pole. Trying to breakout of it. 🟢Trdaing right at 50 DMA. Formed a bullish Marabozu at 50 DMA. 🟢Bullish sentiments of Jewellery stocks around marriage season. 🔴 Q2 results around the corner. If the results are not as per the market then good chance for hitting SL. 🔴Overall bearish sentiments in the market. Watch this counter closely. Risk is in the range of 10-11%. If ATH is broken with good volume and a good candle very good chance for further upmove. Do your due diligence.
NSE:KALYANKJILLong
by sagartharayil
Muhurat Day Investment Pick for long Term (ABSLAMC)Hello everyone, i wish you all Happy Deepawali and new sanvat Year, i hope new year brings you good wealth and good health. Today i am publishing a stock on special day (MUHURAT TRADING DAY), It is a long term investment idea from my side, i am also holding this stock and today again i have added in my portfolio. Stock is really good having good management and right now stock has given Rounding bottom pattern breakout with huge volume. All the levels i already have written on chart. I am expecting huge rally ahead in it, think for long term like 10 years plus and you will get huge returns. About:- Incorporated in 1994, Aditya Birla Sun Life AMC is set up as a joint venture between Aditya Birla Capital Ltd and Sun Life AMC. The Co. offers Mutual Fund services, Portfolio Management services, offshore and real estate offerings. Key Points:- India’s Leading AMC ABSBL is one of the largest non-bank affiliated AMC in India managing AUM of ₹6002 bn under its suite of mutual funds, portfolio management services, offshore and real estate offerings Market Cap ₹ 23,138 Cr. Current Price ₹ 802 High / Low ₹ 804 / 436 Stock P/E 25.8 Book Value ₹ 113 Dividend Yield 1.67 % ROCE 34.9 % ROE 27.4 % Face Value ₹ 5.00 Industry PE 22.6 Debt ₹ 75.0 Cr. EPS ₹ 31.1 Promoter holding 75.0 % Intrinsic Value ₹ 382 Pledged percentage 0.00 % EVEBITDA 19.0 Change in Prom Hold -0.05 % Profit Var 5Yrs 11.8 % Sales growth 5Years 3.05 % Return over 5years % Debt to equity 0.02 Net profit ₹ 896 Cr. ROE 5Yr 30.9 % Profit growth 34.8 % Earnings yield 5.14 % PEG Ratio 2.19 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
NSE:ABSLAMCLong
by TraderRahulPal
2
After falling 25% Nifty50 stock is giving good entry to go long Hello Everyone, i hope you all will be doing good in your trading and your life as well. Today i have brought Bajaj-Auto stock which has fallen 25% from all time high and now trading at importance support zone, There is higher probability for reversal from these levels. It is giving good entry for short term to long term traders and investors. Bajaj Auto, the flagship company of Bajaj Group, is a two-wheeler and three-wheeler manufacturing company that exports to 79 countries across several countries in Latin America, Southeast Asia, and many more. Its headquarter is in Pune, India. It has acquired 48% of the KTM Brand which manufactures sports and super sports two-wheelers, which was 14% in 2007 when the company first acquired KTM. Market Leadership:- The company is the 2nd-largest player in the domestic motorcycle segment in terms of volume. It is the largest 3W producer in the world and the largest exporter of 2W and 3W from India. Manufacturing Capacity:- The company has five manufacturing plants, of which two are in Chakan and one each in Waluj, Akurdi, and Pantnagar, with a total installed capacity of 7.1 million units per annum. Expansion:- In FY24, the company set up a new plant in Brazil with an initial capacity of 20k units/ month that commenced commercial production on Jun 24. It will incur capex of Rs. 600 Cr -Rs. 700 Cr in FY25-FY26, largely towards maintenance activities. Vehicle Financing:- Its wholly-owned captive financing company Bajaj Auto Credit Ltd. commenced business in Maharashtra and Goa on 1st Jan 24 and expanded to Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, Telangana, Rajasthan, and Gujarat. It plans to cover all the balance states by FY25. On Apr 24, the board approved additional investment in BACL of Rs. 2250 Cr, in addition to the existing Rs. 600 Cr approved earlier, to fund its expansion plans. Market Cap ₹ 2,72,363 Cr. Current Price ₹ 9,753 High / Low ₹ 12,774 / 5,285 Stock P/E 36.9 Book Value ₹ 1,109 Dividend Yield 0.80 % ROCE 33.5 % ROE 26.5 % Face Value ₹ 10.0 Industry PE 64.6 Debt ₹ 5,245 Cr. EPS ₹ 263 Promoter holding 55.0 % Intrinsic Value ₹ 3,891 Pledged percentage 0.01 % EVEBITDA 25.8 Change in Prom Hold -0.01 % Profit Var 5Yrs 10.7 % Sales growth 5Years 8.13 % Return over 5years 25.2 % Debt to equity 0.17 Net profit ₹ 7,371 Cr. ROE 5Yr 21.8 % Profit growth 7.74 % Earnings yield 3.64 % PEG Ratio 3.46 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:BAJAJ_AUTOLong
by TraderRahulPal
2
Dr Reddy is Ready to fly in blue sky, Short term Trading Idea .I hope you all will be doing good in your life and your trading as well. I have brought a stock which has formed a pull back pattern and taken support at previous breakout zone. Stock name is Dr. Reddy's Laboratories Ltd and it is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Stock is good for short term trading idea as it has taken support in the previous breakout zone. Stock is good for long term investing as well. This can be best SIP stock to invest and get handsome returns in future. Market Cap ₹ 1,09,439 Cr. Current Price ₹ 1,312 High / Low ₹ 1,421 / 1,041 Stock P/E 19.7 Book Value ₹ 339 Dividend Yield 0.61 % ROCE 26.5 % ROE 21.4 % Face Value ₹ 1.00 Industry PE 34.5 Debt ₹ 2,002 Cr. EPS ₹ 66.7 Promoter holding 26.6 % Intrinsic Value ₹ 1,033 Pledged percentage 0.00 % EVEBITDA 12.3 Change in Prom Hold -0.01 % Profit Var 5Yrs 24.4 % Sales growth 5Years 12.6 % Return over 5years 18.9 % Debt to equity 0.07 Net profit ₹ 5,565 Cr. ROE 5Yr 16.7 % Profit growth 17.8 % Earnings yield 6.77 % PEG Ratio 0.81 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
Editors' picks
NSE:DRREDDYLong
by TraderRahulPal
7
Long Term & Short Term Investing Always Invest Minimum For 4.8 Year.  You Can Get Better Then Mutual Fund    Longterm Investing Minimum Time is 4.8 Year. For Longterm Investment I Prefer 1000-1500 CR Market Cap Company Below 3 Year I Invest in SME /MicroCap. Small Company High Risk So Can’t Assume 5-10 Year Plan. Disclaimer : This is NOT Investment Advice. This Post is Meant for Learning Purposes Only. Invest Your Capital at Your Own Risk. Happy Learning. Cheers!! Shyorawat Arun Singh ❤️ (@Shyorawat_ArunSingh) Founder : Shyorawat Capital
INDEX:BTCUSDEducation
by SHYORAWAT_ARUNSINGH
Short Term Trading idea in Dr. Lal Pathlabs, 17% upside possibleHello everyone, i hope you all will be doing good in your life and your trading as well. Today i have just brought a short term idea in Lab stocks. Stock name is Dr. Lal Pathlabs Ltd. and it is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. Stock has given near term consolidation breakout on daily and weekly time frame. Stock can travel towards all time high levels from here, I have already mention all the levels like stop loss and Targets. Stock is really good for long term investing as well. But for now i have just added kind of short term Idea. Please follow the levels. Market Cap ₹ 29,198 Cr. Current Price ₹ 3,494 High / Low ₹ 3,525 / 1,943 Stock P/E 76.5 Book Value ₹ 222 Dividend Yield 0.69 % ROCE 25.2 % ROE 20.4 % Face Value ₹ 10.0 Industry PE 53.6 Debt ₹ 247 Cr. EPS ₹ 45.7 Promoter holding 54.6 % Intrinsic Value ₹ 743 Pledged percentage 0.00 % EVEBITDA 40.4 Change in Prom Hold 0.00 % Profit Var 5Yrs 12.4 % Sales growth 5Years 13.1 % Return over 5years 20.9 % Debt to equity 0.13 Net profit ₹ 386 Cr. ROE 5Yr 21.3 % Profit growth 44.6 % Earnings yield 1.97 % PEG Ratio 6.15 Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades. Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's. Thankyou.
NSE:LALPATHLABLong
by TraderRahulPal
1
Cosmic Collision: DLF & Oberoi Realty Clash in Real-Estate Space◉ Abstract The Indian real estate market is growing fast and is expected to reach $1 Trillion by 2030. Two big companies in this field are DLF and Oberoi Realty. DLF makes most of its money from commercial properties mainly through rental income, while Oberoi Realty focuses on homes. Both companies are doing well, but Oberoi Realty is growing faster and making more profit. DLF's stock price might go up soon after being stable for a long time. Oberoi Realty's stock has been going up steadily. Both companies don't have too much debt and are attracting investors. DLF seems expensive when you look at its price compared to earnings, while Oberoi Realty looks like a better deal. Oberoi Realty is also spending more on growing its business. In the end, both companies are in a good position to benefit from India's growing economy and increasing demand for real estate. ◉ Introduction The Indian real estate sector has witnessed significant growth in recent years, driven by increasing demand, policy reforms, and infrastructure development. Two prominent players, DLF Limited and Oberoi Realty Limited, have been at the forefront of this growth, shaping the country's urban landscape. Both companies have established themselves as leaders in the industry, with a strong presence in residential, commercial, and retail segments. ◉ Indian Real Estate Sector: Future Growth Prospects India's real estate market is expected to register significant growth in the coming years, driven by a number of factors. Here's a quick summary of the key trends: ● Market size and GDP contribution: The market size is expected to reach US$ 1 trillion by 2030, up from US$ 200 billion in 2021, and contribute 15.5% to GDP by 2047. ● Residential market growth: The residential market is witnessing strong growth, with the value of home sales reaching an all-time high of Rs. 3.47 lakh crore (US$ 42 billion) in FY23. Demand is surging in top 8 cities across mid-income, premium, and luxury segments. ● Retail and office space: The retail and office space segments are also growing rapidly. Gross leasing in top 7 cities crossed 60 million sq ft for the first time in 2023, with technology companies leading leasing activity. ● Data centers: Data center demand is on the rise, with an expected increase of 15-18 million sq ft by 2025. ● Housing shortage: There is a significant housing shortage in urban areas, with the current shortage estimated at 10 million units. An additional 25 million units of affordable housing are required by 2030. Overall, the Indian real estate sector presents a promising picture for growth and development. The sector is benefiting from a number of factors, including a growing economy, rising urbanization, and increasing disposable incomes. This is leading to strong demand for both residential and commercial properties. ◉ Company Overviews ● DLF NSE:DLF DLF Limited, along with its subsidiaries, focuses on colonization and real estate development across India. Their activities encompass land acquisition, project planning, construction, and marketing. The company specializes in developing and selling residential projects, while also managing commercial office spaces and retail properties, including malls and hospitality ventures. Notably, it owns The Lodhi Hotel and Hilton Garden Inn in New Delhi, as well as the DLF Golf & Country Club in Gurugram. Additionally, DLF is involved in leasing, maintenance, power generation, and recreational services. Established in 1946, DLF Limited is headquartered in Gurugram and operates as a subsidiary of Rajdhani Investments and Agencies Private Limited. ● Oberoi Realty NSE:OBEROIRLTY Oberoi Realty Limited, along with its subsidiaries, focuses on real estate development and hospitality in India. It operates in two main segments: Real Estate and Hospitality. The company develops and sells various projects, including residential, commercial, hospitality, retail, and social infrastructure. It also leases office and retail spaces. Additionally, it manages hotel operations, which include room sales, food and beverage services, and related offerings, as well as constructing residential apartments and providing property management services. Established in 1998, the company is based in Mumbai, India. ◉ Market Capitalization ● DLF - ₹ 2,26,256 Cr. ($26.8 B) ● Oberoi Realty - ₹ 68,970 Cr. ($8.2 B) ◉ Relative Strength The chart vividly demonstrates that neither company has managed to surpass the performance of the real estate sector over the past year. The realty sector has achieved an impressive return of 94%, while DLF and Oberoi Realty have delivered returns of 73% and 67%, respectively. ◉ Technical Aspects ● DLF ➖ Since its listing in July 2007, DLF reached an impressive peak of ₹ 1046 in January 2008. ➖ However, the stock faced a significant decline following the Lehman Brothers crisis later that year. ➖ After enduring a lengthy period of consolidation lasting eight years, the price stabilized around ₹ 66 in February 2016 and began its upward trajectory. ➖ Now, after nearly 17 years of consolidation, the stock is trading just below a critical resistance level, with a breakout anticipated in the near future. ● OBEROIRLTY ➖ Since its launch in December 2010, Oberoi Realty has shown a consistent upward trajectory ➖ During this ascent, the stock formed a Bullish Pennant pattern, and after breaking out, it surged to an all-time high of ₹ 1970 in September 2024. ➖ Currently, it is trading just below this peak. Analysts expect the stock to continue its upward momentum and reach new heights in the coming days. ◉ Revenue Breakdown ● DLF DLF mainly generates its revenue from real estate development, concentrating on both commercial and residential areas. Significantly, the commercial real estate sector contributes a considerable 74% of the company's total revenue, largely through rental income. ● OBEROIRLTY The company predominantly earns around 97% of its revenue from the real estate development sector. Furthermore, it also participates in the hospitality industry, which adds the remaining 3% to its overall revenue. ◉ Revenue & Profit Analysis ● DLF ➖ Over the past three years, DLF has recorded a modest compounded annual growth rate of 6% in sales. ➖ Despite this, the company has seen remarkable profit growth, which surged by 33% during the same timeframe. ➖ Currently, DLF enjoys a robust operating profit margin of 33%, an increase from 30% in FY23. ➖ In fiscal year 2024, earnings per share have jumped to 11.02, up from 8.22 the previous year, reflecting a consistent upward trend in EPS over the last four years. ● OBEROIREALTY ➖ In the last three years, Oberoi Realty has achieved an impressive compounded annual growth rate of 30% in sales. ➖ Profit growth has closely mirrored this success, with a CAGR of 34% during the same period. ➖ The company currently boasts an outstanding operating profit margin of 55%, a figure that continues to rise. ➖ While the EPS growth from FY23 to FY24 is modest, with EPS standing at 52.99 compared to 52.38 the previous year, the overall trend in EPS has been positive over the last four years. ◉ Valuation ● P/E Ratio ➖ DLF's current price-to-earnings (P/E) ratio stands at 79.6, slightly exceeding its 1-year median P/E of 76.7. However, when juxtaposed with the industry average of 34.4, it becomes evident that DLF is significantly overvalued at this time. ➖ In contrast, Oberoi Realty presents a P/E ratio of 31.50, which is just above its 1-year median P/E of 29.6. Yet, when compared to the industry P/E of 34.4, it appears to be undervalued. ● P/B Ratio ➖ DLF's price-to-book (P/B) ratio is 5.74, indicating a substantial overvaluation relative to the industry average of 3.54. ➖ Similarly, Oberoi Realty also seems overvalued with a P/B ratio of 4.98. ● PEG Ratio ➖ Oberoi Realty's PEG ratio of 1.83 positions it as an attractive investment opportunity, especially when compared to DLF's considerably higher PEG of 4.79. ◉ Profitability Analysis ➖ DLF ROCE - 6% in FY24 ➖ OBEROIRLTY ROCE - 15% in FY24 ➖ These numbers clearly demonstrate that Oberoi Realty is more profitable than DLF, as it efficiently leverages its total capital—comprising both equity and debt—to yield higher returns. ◉ Capex Analysis ● DLF ➖ The cash flow statement for DLF reveals a negative capital expenditure, indicating that the company is selling or disposing of its existing capital assets. ➖ This suggests a strategic decision to reduce its portfolio of office spaces and similar fixed assets, as they are no longer deemed necessary. ● OBEROIRLTY ➖ In contrast, Oberoi Realty has ramped up its capital expenditure from 601 crore to 677 crore compared to the previous year. ➖ This increase is a positive sign for the company, reflecting its ambition for expansion and growth in the market. ◉ Cash Flow Analysis ➖ DLF has demonstrated impressive growth in its operating cash flow, rising to 2,539 crore from 2,375 crore in FY23. ➖ Oberoi Realty has also performed exceptionally well, transforming its cash from operations to an impressive 2,810 crore, marking a significant recovery from a considerable negative of 2,383 crore in FY23. ◉ Debt Analysis ➖ DLF demonstrates robust financial health with a manageable debt level of 4,894 crores and an impressive debt to equity ratio of just 0.12, signaling that debt is not a significant issue for the company. ➖ On the other hand, Oberoi has a debt of 2,495 crores, resulting in a debt to equity ratio of 0.18, which indicates that the company is also not worried about its debt situation. ◉ Shareholding Pattern ● DLF ➖ Currently, Foreign Institutional Investors (FIIs) possess a 16.17% stake, reflecting a decline from the previous quarter. ➖ On the other hand, Domestic Institutional Investors (DIIs) have increased their holdings to 4.81% as of the June quarter, a slight rise from 4.77% in the last quarter. ● OBEROIRLTY ➖ Foreign Institutional Investors (FIIs) have made a notable increase in their investment in this stock, now holding 18.05%, up from 16.96% in the last quarter. ➖ Conversely, Domestic Institutional Investors (DIIs) have reduced their stake to 12.30%, down from 12.83% in the March quarter. ◉ Conclusion After a comprehensive assessment of the technical and financial metrics, we have concluded that Oberoi Realty has surpassed DLF in terms of valuation, profitability, revenue growth, and future expansion prospects. However, this does not imply that DLF cannot enhance its performance in the future. In fact, DLF is on the verge of a significant multi-year breakthrough, and if this happens, it could create an excellent opportunity for investors to take advantage of any price declines. In the end, both companies exhibit strong growth potential as they are leaders in the real estate sector. As the economy continues to grow, both Oberoi Realty and DLF are well-positioned to capitalize on this expansion.
NSE:DLFLong
by GoodluckCapital
3
Exide Industries Have A Look Exide Industries Touch All Time High In a Month Of July And Cool Down and following a Trend line After Following The Trendline . The Stock Given Us Breakout Of Trendline . There My Point Of View , The Stock Have A more Potential to Touch Again AllTime High its Move in Percentage 18% Can Move After A Good Pull Back . 52 Week High Magnetic Setup Activate & Give Us Gain Of 17-18% from Breakout . Please Look at In This Chart . Thank You For Giving Time On My Post .
NSE:EXIDEINDLong
by trader_addy